The Annals Holiday Offer - Save 50%
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 20 January 2009, www.theannals.com, DOI 10.1345/aph.1L492.
 The Annals of Pharmacotherapy: Vol. 43, No. 2, pp. 356-359. DOI 10.1345/aph.1L492
© 2009 Harvey Whitney Books Company.
This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.

La Seguridad de la Vacuna contra el Virus de Papiloma Humano en Pacientes Pediátricos. Evaluación del Vaccine Adverse Event Reporting System

NL Borja-Hart, S Benavides, y C Christensen

Ann Pharmacother 2009;43: 356-9.

Reportes recientes en los medios noticiosos han vinculado la vacuna contra el Virus de Papiloma Humano (HPV) con eventos adversos en niños y adolescentes. La base de datos del sistema de reporte de eventos adversos a vacunas (VAERS), fue utilizado para extraer eventos adversos post-mercadeo en pacientes que recibieron la vacuna de HPV. En los Estados Unidos de América se han reportado al VAERS 3174 eventos adversos que ocurrieron en niños y adolescentes entre las edades de 6–17 años desde que la vacuna se aprobó. De estos eventos adversos reportados, 191 (6%) se consideran serios. Aunque los eventos adversos reportados se consideran serios, es necesario llevar a cabo más estudios para poder correlacionar estos con la vacuna.

Traducido por Wanda T Maldonado

www.theannals.com, DOI 10.1345/aph.1L492



This Article
Right arrow Abstract Freely available
Right arrow Résumé Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borja-Hart, N. L
Right arrow Articles by Christensen, C.

homecopy help contact us subscription past issues search current issue
Copyright © 2009 by Harvey Whitney Books Company.